2195-44-0

Basic information

• Product Name: 2-BROMO-N-(4-FLUORO-PHENYL)-ACETAMIDE
• Synonyms: 2-BROMO-N-(4-FLUORO-PHENYL)-ACETAMIDE;AKOS BB/0109;CHEMBRDG-BB 4023666;AKOS BBB/461;acetamide, 2-bromo-N-(4-fluorophenyl)-;2-bromo-N-(4-fluorophenyl)acetamide(SALTDATA: FREE);2-bromo-N-(4-fluorophenyl)ethanamide;Acetamide, N-(4-fluorophenyl)-2-bromo-
• CAS NO: 2195-44-0
• Molecular Formula: C₈H₇BrFNO
• Molecular Weight: 232.05
• Mol File: 2195-44-0.mol
• Article Data: 43

Chemical Properties

• Melting Point: 137-138 °C
• Boiling Point: 349.5 °C at 760 mmHg
• Flash Point: 165.2 °C
• Appearance: /
• Density: 1.658 g/cm³
• Vapor Pressure: 4.69E-05mmHg at 25°C
• Refractive Index: 1.606
• PKA: 11.51±0.70(Predicted)
• CAS DataBase Reference: 2-BROMO-N-(4-FLUORO-PHENYL)-ACETAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-N-(4-FLUORO-PHENYL)-ACETAMIDE(2195-44-0)
• EPA Substance Registry System: 2-BROMO-N-(4-FLUORO-PHENYL)-ACETAMIDE(2195-44-0)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 2195-44-0(Hazardous Substances Data)

Usage

General Description

2-BROMO-N-(4-FLUORO-PHENYL)-ACETAMIDE, also known as 2-bromo-4'-fluoroacetanilide, is an organic compound that belongs to the acetanilide class of chemicals. It is a derivative of acetanilide and contains a bromine atom and a 4-fluorophenyl group attached to the amide functional group. 2-BROMO-N-(4-FLUORO-PHENYL)-ACETAMIDE has applications in the pharmaceutical industry as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. It is also used in research and development as a building block in organic synthesis. The chemical properties and structure of 2-BROMO-N-(4-FLUORO-PHENYL)-ACETAMIDE make it a valuable tool in the creation of diverse compounds with potential therapeutic and agricultural properties.

InChI:InChI=1/C8H7BrFNO/c9-5-8(12)11-7-3-1-6(10)2-4-7/h1-4H,5H2,(H,11,12)

Upstream product

• 22118-09-8 2-bromoacetyl chloride 
• 371-40-4 4-fluoroaniline 
• 598-21-0 2-Bromoacetyl bromide 
• 79-08-3 bromoacetic acid 
• 683-57-8 bromo-acetic acid amide 

Downstream Products

• 1235477-20-9 2-(5-acetyl-3-benzyl-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)-N-(4-fluorophenyl)acetamide 
• 1160748-08-2 2-azido-N-(4-fluorophenyl)acetamide 
• 1550168-68-7 2-(4-((3-amino-6-phenyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)-N-(4-fluorophenyl)acetamide 
• 303063-09-4 C₁₅H₁₂FN₃OS₂ 
• 309922-92-7 C₁₈H₂₀FN₃O 
• 1401333-58-1 C₁₇H₂₄FN₃O₃ 
• 1052418-64-0 C₁₂H₁₆FN₃O*ClH 
• 1009171-63-4 N-(4-fluorophenyl)-2-(2-(thiazol-4-yl)-1H-benzo[d]imidazol-1-yl)acetamide 
• 899710-97-5 N-(4-fluorophenyl)-2-(4-((4-methoxyphenyl)sulfonyl)-piperazin-1-yl)acetamide 
• 1286504-25-3 N-(4-fluorophenyl)-2-(4-((2-fluorophenyl)sulfonyl)-piperazin-1-yl)acetamide 
• 712345-09-0 N-(4-fluorophenyl)-2-(4-((4-fluorophenyl)sulfonyl)-piperazin-1-yl)acetamide 
• 1370556-89-0 N-(4-fluorophenyl)diethylphosphonoacetamide 
• 1263104-20-6 N-(4-fluorophenyl)-2-(8-methyl-6-phenyldipyrazolo[3,4-b:3',4'-d]pyridin-1(6H)yl)acetamide 

Relevant articles and documents

Synthesis, anticancer, and computational studies of 1, 3, 4-oxadiazole-purine derivatives

Theophylline-7-acetic acid (acefylline) (3) and its derivatives are pharmacologically active compounds and generally recognized as bronchodilators for the treatment of respiratory diseases like acute asthma for over 70 years. In this article, synthesis of

Synthesis and Anti-Inflammatory Properties of Substituted 5-(Tetrahydro-4-phenyl-2H-pyran-4-yl)-4H-1,2,4-triazole-3-thiols

Abstract: 5-(Tetrahydro-4-phenyl-2H-pyran-4-yl)-4H-1,2,4-triazole-3-thiol was synthesized by the reaction of 4-phenyltetrahydropyran-4-carbonyl chloride with thiosemicarbazide and subsequent cyclization of the resulting amide in the presence of KOH. The c

Pyrazoline tethered 1,2,3-triazoles: Synthesis, antimicrobial evaluation and in silico studies

A new series of pyrazoline-amide linked 1,2,3-triazole hybrids was wisely designed and synthesized using 1,3-dipolar cycloaddition between pyrazoline linked alkynes and 2-bromo-N-arylacetamide. All the newly synthesized compounds were evaluated in vitro against different microbial strains viz. Escherichia coli, Bacillius subtilis, Staphylococcus aureus, Aspergillus niger, and Candida albicans. Pyrazoline linked terminal alkynes (4a–c) showed MIC = 0.062–0.078 μmol/mL against different bacterial and fungal strain. However, pyrazoline-amide linked 1,2,3-triazole hybrids (6a-6t) showed MIC = 0.0229–0.050 μmol/mL. Compound 6e exhibited better efficacy against E. coli and both the fungal strains compared to standard drugs used. Docking studies of the most potent compounds were carried out against bacterial DNA Gyr A and fungal 14α-steroldemethylase were also performed. The binding potential of 4a and 6e with both the target using molecular dynamics simulations was also investigated.